Skip to main content
Peptide Intel Hub laboratory research video
Peptide Intel Hub

Protocols · Longevity

MOTS-c: literature-reported ranges

MOTS-c is encoded in mitochondrial DNA and studied for its effects on AMPK signalling, insulin sensitivity and exercise capacity. The literature is rodent and in-vitro; no human dosing trial has been published.

Read this first

Every figure on this page is a range reported in published literature or in a publicly documented study protocol. It is a record of what researchers used, not a recommendation, a therapeutic protocol, or advice. Peptide Intel Hub is an independent publication, sells nothing, and describes these compounds as in-vitro research reagents only.

Compound at a glance

Class
Mitochondrial-derived peptide (16 amino acids)
Reported half-life
Short in plasma; tissue uptake studies use longer sampling windows
Routes used in the literature
Intraperitoneal and subcutaneous in animal work
Also written as

What the published studies reported

Each row below describes one body of work. The model and population are part of the figure — a rodent per-kilogram quantity and a human trial quantity are not comparable.

Mouse metabolic and exercise-capacity studies

Reported quantity
5–15 mg/kg body weight
Frequency
Once daily or every other day
Study duration
2–8 weeks depending on endpoint

The 5 mg/kg daily arm is the most frequently repeated design.

In-vitro AMPK signalling

Reported quantity
0.1–10 µM in culture media
Frequency
Single exposure
Study duration
1–24 hours

AMPK phosphorylation and glucose uptake are the standard readouts.

Dosage chart

These figures match the published chart for this compound on peptidedosages.com, including the reconstitution volume, resulting concentration, insulin-syringe units and the staged schedule. Educational reference only — not instructions, and not medical advice.

MOTS-c · 10 mg Vial

MOTS-c is dosed at 200 mcg–1 mg administered daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 3.33 mg/mL. Most protocols titrate gradually over roughly 10 weeks. This information is for research and educational use only.

Reconstitute
Add 3.0 mL bacteriostatic water → ~ 3.33 mg/mL concentration.
Typical daily range
200–1,000 mcg once daily (gradual titration over 10 weeks).
Easy measuring
At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe.
Storage
Lyophilized: freeze at −20 °C (−4 °F) or below; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days for best potency.

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

WeekDaily Dose (mcg)Units (per injection) (mL)
Weeks 1–2200 mcg (0.2 mg)6 units (0.06 mL)
Weeks 3–4400 mcg (0.4 mg)12 units (0.12 mL)
Weeks 5–6600 mcg (0.6 mg)18 units (0.18 mL)
Weeks 7–8800 mcg (0.8 mg)24 units (0.24 mL)
Weeks 9–10+1,000 mcg (1.0 mg)30 units (0.30 mL)
Source chart on peptidedosages.com

Mixed with 3 ml of bacteriostatic water

The same arithmetic for every vial size MOTS-c is supplied in, using a fixed 3 ml of bacteriostatic water. One unit on a U-100 insulin syringe is 0.01 ml, so the unit column below is simply the volume that carries the reported amount. Educational arithmetic only — not instructions, and not medical advice.

MOTS-c · 3 ml bacteriostatic water

Vial sizeConcentrationPer 1 unit200 mcg =1 mg =
10 mg3.33 mg/ml33 mcg6.0 units30 units
40 mg13.33 mg/ml133 mcg1.5 units7.5 units

Unit columns use the range reported for this compound (200 mcg–1 mg). Only the vial sizes this compound is actually supplied in are shown, and every figure assumes exactly 3 ml of bacteriostatic water. For any other volume, use the reconstitution calculator.

Reconstitution maths

A 10 mg vial in 2 mL of bacteriostatic water gives 5 mg/mL.

Open the reconstitution calculator

How to read these figures

  • Rodent mg/kg figures translate very poorly to other species for peptides with rapid clearance.
  • Endogenous MOTS-c levels vary with age and exercise, which complicates baseline interpretation.
  • Mitochondrial peptides are a young field — expect the published ranges to move.

Sources and citations

These are the published records the figures on this page are drawn from. Each one describes what researchers administered, in which model or population, and over what period. Quantities reported in a study are specific to that study's design and are not transferable guidance.

  1. [1]
    MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

    Reynolds JC, Lai RW, Woodhead JST, et al. · Nat Commun · 2021 · PMID (see PMC7817689)

    Aged mice received daily intraperitoneal injections of MOTS-c (15 mg/kg) for 2 weeks to assess effects on physical performance and muscle metabolism.

    View the record
  2. [2]
    MOTS-c increases in skeletal muscle following long-term physical activity and improves acute exercise performance after a single dose

    Reynolds JC, Lai RW, et al. · Physiol Rep · 2022 · PMCID PMC9270643

    Mice were given a single intraperitoneal dose of MOTS-c (15 mg/kg) prior to acute treadmill exercise testing to assess performance effects.

    View the record
  3. [3]
    The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance

    Lee C, Zeng J, Drew BG, et al. · Cell Metab · 2015 · DOI (ScienceDirect S1550413115000613)

    Mice fed high-fat diet received daily intraperitoneal MOTS-c injections (15 mg/kg) to evaluate effects on insulin resistance and obesity.

    View the record

Search the databases yourself

Read the MOTS-c research brief

Other longevity compounds

All research protocols

Peptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.

Share
© 2026 Peptide Intel Hub · Marbella · Educational research reference · For in-vitro research use only
Independent publication — we sell nothing. Supplier disclosure

Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Regena Peptides and Regena.app (regena-peptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Regena Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.